KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Operating Leases: 2019-2025

Historic Operating Leases for Opko Health (OPK) over the last 6 years, with Sep 2025 value amounting to $36.3 million.

  • Opko Health's Operating Leases fell 44.02% to $36.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.3 million, marking a year-over-year decrease of 44.02%. This contributed to the annual value of $48.8 million for FY2024, which is 9.77% down from last year.
  • Latest data reveals that Opko Health reported Operating Leases of $36.3 million as of Q3 2025, which was down 23.17% from $47.2 million recorded in Q2 2025.
  • Opko Health's 5-year Operating Leases high stood at $64.8 million for Q3 2024, and its period low was $28.0 million during Q4 2022.
  • Its 3-year average for Operating Leases is $49.4 million, with a median of $48.2 million in 2025.
  • As far as peak fluctuations go, Opko Health's Operating Leases spiked by 93.61% in 2023, and later plummeted by 44.02% in 2025.
  • Opko Health's Operating Leases (Quarterly) stood at $33.1 million in 2021, then fell by 15.51% to $28.0 million in 2022, then soared by 93.61% to $54.1 million in 2023, then decreased by 9.77% to $48.8 million in 2024, then tumbled by 44.02% to $36.3 million in 2025.
  • Its last three reported values are $36.3 million in Q3 2025, $47.2 million for Q2 2025, and $48.2 million during Q1 2025.